Home » Topics » BioWorld Science

BioWorld Science
RSS

CD38 as therapeutic target for protection against doxorubicin-induced cardiotoxicity

Oct. 14, 2021

Suicide attempters with schizophrenia show increased serum S-100B protein levels

Oct. 14, 2021

New adenosine receptor antagonists synthesized at Exelixis

Oct. 14, 2021

Beijing Jacobio Pharmaceuticals patents KRAS mutant protein inhibitors

Oct. 14, 2021

LG Chem discovers GLP-1 receptor agonists

Oct. 14, 2021

Heptares Therapeutics describes new GLP-1 and GLP-2 receptor agonists

Oct. 14, 2021

New EGFR inhibitors identified at PharmaBlock Sciences

Oct. 14, 2021

BDNF and NSE as biomarkers in alcohol use disorder and mood disorder comorbidity

Oct. 14, 2021

AMPK is a therapeutic target in PDAC

Oct. 14, 2021

Engineered microbial therapy for local metabolic modulation of the tumor microenvironment

Oct. 14, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...